Argon plasma coagulation for endoscopic treatment for congenital pyriform sinus fistula in children

Yanyan Wang1,2, Youtao Chen1,2,3, Hailin Wu1,2

  • 1Department of Gastroenterology, Fujian Children's Hospital(Fujian Branch of Shanghai Children's Medical Center), No. 966, Hengyu Road, Fuzhou, Fujian Province, 350014, China.

BMC Pediatrics
|June 19, 2026
PubMed

Insights

Argon plasma coagulation (APC) offers a safe and effective endoscopic treatment for congenital pyriform sinus fistulas (CPSF) in children. This minimally invasive approach demonstrated no recurrence or complications in a recent pediatric study.

Area of Science:

  • Pediatric Surgery
  • Otolaryngology
  • Gastroenterology

Background:

  • Congenital pyriform sinus fistulas (CPSF) are rare congenital anomalies.
  • Traditional treatments can be invasive and associated with complications.

Purpose of the Study:

  • To evaluate the efficacy of a novel endoscopic approach using argon plasma coagulation (APC) for treating pediatric CPSF.
  • To assess the safety and outcomes of APC in this patient population.

Main Methods:

  • Retrospective analysis of 30 pediatric patients with CPSF treated between 2021 and 2025.
  • Procedures utilized endoscopy-assisted APC.
  • Patients underwent pre- and post-operative diagnostic imaging and follow-up.

Main Results:

  • All 30 APC procedures were successfully completed without immediate complications.
  • No instances of pharyngeal fistula, dysphagia, or infection were reported.
  • Follow-up ranging from 2 weeks to 3 years showed no recurrence of CPSF.

Conclusions:

  • Endoscopy-assisted APC is a promising, minimally invasive treatment for pediatric CPSF.
  • The technique offers advantages such as reduced trauma, minimal bleeding, and clear visualization.
  • APC appears safe and effective, supporting wider clinical adoption for infants and children with CPSF.
Abstract

Related Concept Videos